CN Patent

CN110404079B — 一种不含碳酸盐、低基因毒性杂质含量的喹啉衍生物或其盐的药物组合物

Assigned to Beijing Creatron Institute of Pharmaceutical Research Co Ltd · Expires 2023-01-24 · 3y expired

What this patent protects

本发明提供一种药物组合物，含有(1)4‑(3‑氯‑4‑(N’‑环丙基脲基)苯氧基)‑7‑甲氧基喹啉‑6‑羧酸酰胺或其药学上可接受的盐或溶剂合物，和(2)氨丁三醇。该组合物基因毒性杂质A、B含量低，且不含碳酸盐，稳定、溶出效果好。

USPTO Abstract

本发明提供一种药物组合物，含有(1)4‑(3‑氯‑4‑(N’‑环丙基脲基)苯氧基)‑7‑甲氧基喹啉‑6‑羧酸酰胺或其药学上可接受的盐或溶剂合物，和(2)氨丁三醇。该组合物基因毒性杂质A、B含量低，且不含碳酸盐，稳定、溶出效果好。

Drugs covered by this patent

Patent Metadata

Patent number
CN110404079B
Jurisdiction
CN
Classification
—
Expires
2023-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Creatron Institute of Pharmaceutical Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.